Follow
Elana Simon
Elana Simon
Verified email at alumni.harvard.edu
Title
Cited by
Cited by
Year
Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma
JN Honeyman, EP Simon, N Robine, R Chiaroni-Clarke, DG Darcy, ...
Science 343 (6174), 1010-1014, 2014
4722014
Protein design and variant prediction using autoregressive generative models
JE Shin, AJ Riesselman, AW Kollasch, C McMahon, E Simon, C Sander, ...
Nature communications 12 (1), 2403, 2021
2792021
Transcriptomic characterization of fibrolamellar hepatocellular carcinoma
EP Simon, CA Freije, BA Farber, G Lalazar, DG Darcy, JN Honeyman, ...
Proceedings of the National Academy of Sciences 112 (44), E5916-E5925, 2015
1162015
Chemberta-2: Towards chemical foundation models
W Ahmad, E Simon, S Chithrananda, G Grand, B Ramsundar
arXiv preprint arXiv:2209.01712, 2022
682022
Accelerating protein design using autoregressive generative models
A Riesselman, JE Shin, A Kollasch, C McMahon, E Simon, C Sander, ...
BioRxiv, 757252, 2019
432019
Non coding RNA analysis in fibrolamellar hepatocellular carcinoma
BA Farber, G Lalazar, EP Simon, WJ Hammond, D Requena, UK Bhanot, ...
Oncotarget 9 (12), 10211, 2018
262018
Accelerating protein design using autoregressive generative models. bioRxiv
AJ Riesselman, JE Shin, AW Kollasch, C McMahon, E Simon, C Sander, ...
September, 2019
162019
ChemBERTa-2: towards chemical foundation models. arXiv 2022
W Ahmad, E Simon, S Chithrananda, G Grand, B Ramsundar
arXiv preprint arXiv:2209.01712, 0
7
ChemBERTA-2: Towards chemical foundation models. arXiv
W Ahmad, E Simon, S Chithrananda, G Grand, B Ramsundar
arXiv preprint arXiv:2209.01712 520, 2022
52022
ChemBERTa-2: Towards Chemical Foundation Models. 2022
W Ahmad, E Simon, S Chithrananda, G Grand, B Ramsundar
Publisher: arXiv Version, 0
4
Compounds, compositions and methods of treating disorders
MR Spyvee, JM Kallenbach, A Gupta, E Simon, GJ Grand
US Patent App. 17/744,228, 2022
2022
The Fibrolamellar Registry: A patient-based medical registry can address medical care
JL Newcomb, S Lett, RD Migler, EP Simon, SM Simon
Cancer Research 80 (16_Supplement), 4353-4353, 2020
2020
The fibrolamellar registry: A model for the study of rare diseases
M Desmond, J Latone, S Lett, RD Migler, EP Simon, SM Simon
Cancer Research 79 (13_Supplement), 3357-3357, 2019
2019
Predicting the effects of mutations with alignment-free generative models of protein sequences
AJ Riesselman, JB Ingraham, A Kollasch, EP Simon, JE Shin, ...
Building maps from genetic sequences to biological function, 45, 2019
2019
Molecular analysis of the pediatric cancer fibrolamellar hepatocellular carcinoma
EP Simon, JN Honeyman, DG Darcy, BR Rosenberg, II Lim, JM Murphy, ...
Cancer Research 75 (15_Supplement), 4730-4730, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–15